Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methotrexate with or without high-dose cytarabine plus tailored radiotherapy for newly diagnosed primary CNS lymphoma
2005-001055-38Phase 2Completed
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, cytarabine in primary central nervous system lymphoma (PCNSL), sponsored by International Extranodal Lymphoma Study Group. Started Apr 2007; status: completed.
02
Drugs
methotrexatecytarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on 2005-001055-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001055-38.